Related Experiment Video
Updated: Jun 20, 2026
Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Recent developments in surface-enhanced Raman spectroscopy-based immuno (apta) assays for cardiac troponin detection:
Sreejith K P1, Murukeshan Vadakke Matham2, Santhosh Chidangil1
1Centre of Excellence for Biophotonics, Manipal Institute of Applied Physics, Manipal Academy of Higher Education, Manipal, Karnataka 576104 India.
Abstract:
Cardiac troponin (cTn) is widely recognized as the gold standard for the diagnosis of acute myocardial infarction (AMI), a leading cause of mortality worldwide. Point-of-care testing (POCT) for cTn necessitates rapid turnaround, cost-effectiveness, user-friendly operation, and portability, along with the highest level of accuracy to support timely and effective clinical decision-making. Surface-enhanced Raman spectroscopy (SERS) based assays possess several features suitable for POCT, including the flexibility to integrate with innovative platforms such as microfluidic systems and paper-based devices. In this review, we discuss the recent developments in SERS-based immuno (apta) assays for cTn detection, with a focus on detection strategies, employed platforms, and their feasibility for POCT. This review also outlines the improvements required in existing assays to meet POCT requirements, aiding in the design of future diagnostic assays.
Related Concept Videos
01:25Rapid Identification of Pathogens
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...